360 related articles for article (PubMed ID: 29072694)
1. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.
Sheng W; Chen C; Dong M; Wang G; Zhou J; Song H; Li Y; Zhang J; Ding S
Cell Death Dis; 2017 Oct; 8(10):e3147. PubMed ID: 29072694
[TBL] [Abstract][Full Text] [Related]
2. Calreticulin promotes EMT in pancreatic cancer via mediating Ca
Sheng W; Wang G; Tang J; Shi X; Cao R; Sun J; Lin YH; Jia C; Chen C; Zhou J; Dong M
J Exp Clin Cancer Res; 2020 Oct; 39(1):209. PubMed ID: 33028359
[TBL] [Abstract][Full Text] [Related]
3. Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling.
Sheng W; Shi X; Lin Y; Tang J; Jia C; Cao R; Sun J; Wang G; Zhou L; Dong M
J Exp Clin Cancer Res; 2020 Jan; 39(1):16. PubMed ID: 31952541
[TBL] [Abstract][Full Text] [Related]
4. Numb-PRRL promotes TGF-β1- and EGF-induced epithelial-to-mesenchymal transition in pancreatic cancer.
Sheng W; Tang J; Cao R; Shi X; Ma Y; Dong M
Cell Death Dis; 2022 Feb; 13(2):173. PubMed ID: 35197444
[TBL] [Abstract][Full Text] [Related]
5. GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling.
Huang L; Chen S; Fan H; Ji D; Chen C; Sheng W
Cancer Gene Ther; 2021 Aug; 28(7-8):839-849. PubMed ID: 32747685
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
Sheng W; Chen C; Dong M; Zhou J; Liu Q; Dong Q; Li F
J Cell Physiol; 2014 Jul; 229(7):887-97. PubMed ID: 24264800
[TBL] [Abstract][Full Text] [Related]
7. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
8. Gli1 promotes transforming growth factor-beta1- and epidermal growth factor-induced epithelial to mesenchymal transition in pancreatic cancer cells.
Liu Q; Sheng W; Dong M; Dong X; Dong Q; Li F
Surgery; 2015 Jul; 158(1):211-24. PubMed ID: 25979438
[TBL] [Abstract][Full Text] [Related]
9. FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling.
Chen Y; Liu P; Shen D; Liu H; Xu L; Wang J; Shen D; Sun H; Wu H
Biol Open; 2020 Feb; 9(2):. PubMed ID: 31988090
[TBL] [Abstract][Full Text] [Related]
10. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
11. Alteration of integrin-dependent adhesion and signaling in EMT-like MDCK cells established through overexpression of calreticulin.
Ihara Y; Inai Y; Ikezaki M
J Cell Biochem; 2011 Sep; 112(9):2518-28. PubMed ID: 21557298
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway.
Lei S; He Z; Chen T; Guo X; Zeng Z; Shen Y; Jiang J
J Exp Clin Cancer Res; 2019 Nov; 38(1):470. PubMed ID: 31747939
[TBL] [Abstract][Full Text] [Related]
13. Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway.
Bhat FA; Sharmila G; Balakrishnan S; Arunkumar R; Elumalai P; Suganya S; Raja Singh P; Srinivasan N; Arunakaran J
J Nutr Biochem; 2014 Nov; 25(11):1132-1139. PubMed ID: 25150162
[TBL] [Abstract][Full Text] [Related]
14. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
15. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.
Liu ZC; Chen XH; Song HX; Wang HS; Zhang G; Wang H; Chen DY; Fang R; Liu H; Cai SH; Du J
Cell Tissue Res; 2014 Nov; 358(2):491-502. PubMed ID: 25124796
[TBL] [Abstract][Full Text] [Related]
16. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
17. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
18. MiR-338-5p Inhibits EGF-Induced EMT in Pancreatic Cancer Cells by Targeting EGFR/ERK Signaling.
Sun J; Chen L; Dong M
Front Oncol; 2021; 11():616481. PubMed ID: 33937024
[TBL] [Abstract][Full Text] [Related]
19. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling.
Xie ZB; Zhang YF; Jin C; Mao YS; Fu DL
J Exp Clin Cancer Res; 2019 Feb; 38(1):75. PubMed ID: 30760292
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
Park GB; Ko HS; Kim D
Mol Med Rep; 2017 Aug; 16(2):1826-1836. PubMed ID: 28627617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]